Firefly Neuroscience Files 8-K
Ticker: AIFF · Form: 8-K · Filed: Aug 14, 2024 · CIK: 803578
Sentiment: neutral
Topics: 8-K, disclosure, corporate-events
TL;DR
Firefly Neuroscience dropped an 8-K, check it for Reg FD, other events, and financials.
AI Summary
Firefly Neuroscience, Inc. filed an 8-K on August 14, 2024, to report on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as WAVEDANCER, INC. and INFORMATION ANALYSIS INC, is incorporated in Delaware and headquartered in Kenmore, NY.
Why It Matters
This 8-K filing provides updates on significant corporate events and disclosures for Firefly Neuroscience, Inc., which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting various corporate events and disclosures, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- FIREFLY NEUROSCIENCE, INC. (company) — Registrant
- WAVEDANCER, INC. (company) — Former Company Name
- INFORMATION ANALYSIS INC (company) — Former Company Name
- August 14, 2024 (date) — Date of Report
- 1100 Military Road Kenmore, NY 14217 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Firefly Neuroscience, Inc.?
The 8-K filing serves to report on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of August 14, 2024.
What were Firefly Neuroscience, Inc.'s former names?
Firefly Neuroscience, Inc. was formerly known as WAVEDANCER, INC. and INFORMATION ANALYSIS INC.
In which state is Firefly Neuroscience, Inc. incorporated?
Firefly Neuroscience, Inc. is incorporated in Delaware.
What is the address of Firefly Neuroscience, Inc.'s principal executive offices?
The principal executive offices are located at 1100 Military Road, Kenmore, NY 14217.
What is the IRS Employer Identification Number for Firefly Neuroscience, Inc.?
The IRS Employer Identification Number for Firefly Neuroscience, Inc. is 54-1167364.
Filing Stats: 1,116 words · 4 min read · ~4 pages · Grade level 11.9 · Accepted 2024-08-14 17:24:54
Key Financial Figures
- $0.0001 — on which registered Common Stock , $0.0001 par value per share AIFF The Nasdaq
- $1,708,520 — Dancer reported stockholders' equity of $1,708,520 for the period ended March 31, 2024, wh
Filing Documents
- wavd20240814_8k.htm (8-K) — 36KB
- ex_714679.htm (EX-99.1) — 480KB
- ex_714680.htm (EX-99.2) — 148KB
- 0001437749-24-026884.txt ( ) — 847KB
- wavd-20240814.xsd (EX-101.SCH) — 3KB
- wavd-20240814_def.xml (EX-101.DEF) — 11KB
- wavd-20240814_lab.xml (EX-101.LAB) — 15KB
- wavd-20240814_pre.xml (EX-101.PRE) — 11KB
- wavd20240814_8k_htm.xml (XML) — 3KB
01
Item 7.01 Regulation FD Disclosure. On August 14, 2024, the Company filed its unaudited condensed financial statements for the three and six months ended June 30, 2024 and 2023 (the " Financial Statements "), and management's discussion and analysis for the three and six months ended June 30, 2024 and 2023 (the " MD&A "). The Financial Statements and the MD&A include certain unaudited financial information of the Company for the three and six months ended June 30, 2024. The foregoing descriptions of the Financial Statements and the MD&A do not purport to be complete and are qualified in their entirety by the full text of the Financial Statements and the MD&A, copies of which are attached hereto as Exhibits 99.1 and 99.2 and are incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.
01
Item 8.01 Other Events As previously disclosed, on August 8, 2024, WaveDancer received a letter from the Staff (the " Staff ") of the Nasdaq Stock Market LLC (the " Letter ") indicating that in WaveDancer's Quarterly Report on Form 10-Q filed with the SEC on May 14, 2024, WaveDancer reported stockholders' equity of $1,708,520 for the period ended March 31, 2024, which did not comply with Listing Rule 5550(b)(1) (the " Minimum Stockholders ' Equity Requirement "). As previously reported, in a decision dated November 14, 2023, a Nasdaq Hearings Panel (the " Panel ") confirmed that WaveDancer had regained compliance with the Minimum Stockholders' Equity Requirement for a prior outstanding deficiency under the Minimum Stockholders' Equity Requirement as related to its stockholders' equity for the period ended March 31, 2023. In the decision, the Panel imposed a Mandatory Panel Monitor for a period of one year or until November 14, 2024, which would require the Staff to issue a Delist Determination Letter in the event that WaveDancer failed to maintain compliance with the Minimum Stockholders' Equity Rule (the " Panel Monitor "). On August 13, 2024, the Company received a letter from the Staff noting that following the Staff's review of the Merger, the Staff determined that the Company now complies with the Minimum Stockholders' Equity Requirement and that the matter is now closed.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Unaudited Interim Financial Statements of Firefly Neuroscience, Inc. for the three and six months ended June 30, 2024 and 2023 99.2 Management's Discussion and Analysis of Financial Condition and Results of Operations of Firefly Neuroscience, Inc. for the three months ended June 30, 2024 and 2023 104 Cover Page Interactive Data File
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FIREFLY NEUROSCIENCE, INC. Date: August 14, 2024 By: /s/ Jon Olsen Name: Jon Olsen Title: Chief Executive Officer